Among surgical patients receiving transfusions of packed RBCs (PRBCs), the incidence and degree of transfusion-related immunomodulation are related to, among other factors, the type of product transfused and patient parameters.
Both CV and the BGRI had good predictive ability. The BGRI being a continuous variable could be a preferred measure of glycemic variability in predicting adverse outcomes (cutoff value 2.24) after cardiac surgery.
